Syra Health Corp. (SYRA)
NASDAQ: SYRA · Real-Time Price · USD
0.380
+0.009 (2.43%)
Dec 20, 2024, 4:00 PM EST - Market closed
Syra Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 7.74 | 5.52 | 5.62 | 1.41 | - |
| Revenue Growth (YoY) | 35.47% | -1.83% | 298.43% | - | - |
| Cost of Revenue | 5.97 | 4.11 | 4.59 | 0.98 | - |
| Gross Profit | 1.78 | 1.41 | 1.03 | 0.43 | - |
| Selling, General & Admin | 5.13 | 4.01 | 3.11 | 0.43 | 0.05 |
| Research & Development | 0.83 | 0.24 | - | - | - |
| Operating Expenses | 6.03 | 4.3 | 3.12 | 0.43 | 0.05 |
| Operating Income | -4.25 | -2.89 | -2.09 | -0 | -0.05 |
| Interest Expense | -0.02 | -0.05 | -0.03 | - | - |
| Interest & Investment Income | 0.02 | 0 | 0 | - | - |
| Pretax Income | -4.25 | -2.94 | -2.12 | -0 | -0.05 |
| Net Income | -4.25 | -2.94 | -2.12 | -0 | -0.05 |
| Net Income to Common | -4.25 | -2.94 | -2.12 | -0 | -0.05 |
| Shares Outstanding (Basic) | 7 | 5 | 3 | 1 | 14 |
| Shares Outstanding (Diluted) | 7 | 5 | 3 | 1 | 14 |
| Shares Change (YoY) | 46.18% | 60.40% | 264.93% | -93.94% | - |
| EPS (Basic) | -0.64 | -0.60 | -0.70 | -0.00 | - |
| EPS (Diluted) | -0.64 | -0.60 | -0.70 | -0.00 | - |
| Free Cash Flow | -4.49 | -2.77 | -2.37 | -0.09 | - |
| Free Cash Flow Per Share | -0.67 | -0.57 | -0.78 | -0.11 | - |
| Gross Margin | 22.94% | 25.54% | 18.35% | 30.52% | - |
| Operating Margin | -54.89% | -52.36% | -37.20% | -0.23% | - |
| Profit Margin | -54.90% | -53.28% | -37.71% | -0.23% | - |
| Free Cash Flow Margin | -57.94% | -50.30% | -42.10% | -6.70% | - |
| EBITDA | -4.18 | -2.84 | -2.07 | -0 | - |
| EBITDA Margin | -54.02% | -51.48% | -36.93% | -0.22% | - |
| D&A For EBITDA | 0.07 | 0.05 | 0.01 | 0 | - |
| EBIT | -4.25 | -2.89 | -2.09 | -0 | -0.05 |
| EBIT Margin | -54.89% | -52.36% | -37.20% | -0.23% | - |
| Revenue as Reported | - | - | - | 1.41 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.